- This event has passed.
First in class Hit Finding, the In-Silico Way
February 25, 2021
A show case of our computational chemistry capabilities with emphasis on virtual screening and scaffold-hopping campaigns for first-in-class targets, demonstrated through scientific case studies. Application of latest Machine-learning algorithms to various end-points. Insights into Jubilant Biosys’ current ML model development, as a platform, for CardioTox, including individual classification models for hERG,Nav1.5 and Cav1.2 and many more similar models through the value chain.
- February 25, 2021